Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial

Introduction: Surgical site infection (SSI) is caused by cesarean section in the hospital and its prevalence in the studies is up to 16%. Objectives: This study aimed to compare the rate of infection in women undergoing cesarean section. Oral clindamycin and cefalexin were administered for 48 hours...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farzaneh Broumand, Naghmeh Zand Vakili, Zahra Yekta, Shabnam Vazifekhah
Formato: article
Lenguaje:EN
Publicado: Society of Diabetic Nephropathy Prevention 2022
Materias:
Acceso en línea:https://doaj.org/article/be18b11691914cc3809cac5d3b9944f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:be18b11691914cc3809cac5d3b9944f6
record_format dspace
spelling oai:doaj.org-article:be18b11691914cc3809cac5d3b9944f62021-11-16T10:42:13ZComparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial2476-393410.34172/jpe.2022.07https://doaj.org/article/be18b11691914cc3809cac5d3b9944f62022-01-01T00:00:00Zhttps://jprevepi.com/PDF/jpe-7-e07.pdfhttps://doaj.org/toc/2476-3934Introduction: Surgical site infection (SSI) is caused by cesarean section in the hospital and its prevalence in the studies is up to 16%. Objectives: This study aimed to compare the rate of infection in women undergoing cesarean section. Oral clindamycin and cefalexin were administered for 48 hours as prophylactic antibiotics. Patients and Methods: In this clinical trial study, women with emergency cesarean section were divided into two groups. Intervention was oral administration of cefalexin 500mg every 6 hours and clindamycin 300 mg every 6 hours for 48 hours. All participants were referred to the gynecology center on day 7–10, at the time of removal of the sutures, and within 30 days after cesarean section, to assess the presence or absence of wound infection after surgery during 30 days. Results: In this clinical trial study, 462 pregnant women undergoing cesarean section were enrolled in the intervention and control groups. Of 231 patients in the intervention group, 15 women (6.5%) had cesarean section infection (13 cases with superficial, and 2 cases with deep infection). In the control group, 45 cases (19.5%) had cesarean section infection (31 cases with superficial, 10 cases with deep, and 4 cases with developed pelvic infection) (P = 0.001). Age, pre-cesarean length of stay, pre-term incision, type of incision, discharge longer than 18 hours after cesarean section, and maternal diabetes were significantly different regarding cesarean section infection in both groups. The frequency of cesarean section infection was less in the intervention group (P <0.001). Conclusion: Administration of prophylactic antibiotic can have a significant role in reducing cesarean section infection. Trial Registration: Registration of trial protocol has been approved in Thailand registry of clinical trials (identifier: TCTR20201204002, http://www.clinicaltrials.in.th/index.php?tp=regtrials & menu=trialsearch & s-menu=fulltext & task=search & task2=view1 & id=7120, ethical code; IR.UMSU.REC.1397.323).Farzaneh BroumandNaghmeh Zand VakiliZahra YektaShabnam VazifekhahSociety of Diabetic Nephropathy Preventionarticlesuperficial infectiondeep infectionpelvic infectioncesareanSpecialties of internal medicineRC581-951Infectious and parasitic diseasesRC109-216ENJournal of Preventive Epidemiology, Vol 7, Iss 1, Pp e07-e07 (2022)
institution DOAJ
collection DOAJ
language EN
topic superficial infection
deep infection
pelvic infection
cesarean
Specialties of internal medicine
RC581-951
Infectious and parasitic diseases
RC109-216
spellingShingle superficial infection
deep infection
pelvic infection
cesarean
Specialties of internal medicine
RC581-951
Infectious and parasitic diseases
RC109-216
Farzaneh Broumand
Naghmeh Zand Vakili
Zahra Yekta
Shabnam Vazifekhah
Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
description Introduction: Surgical site infection (SSI) is caused by cesarean section in the hospital and its prevalence in the studies is up to 16%. Objectives: This study aimed to compare the rate of infection in women undergoing cesarean section. Oral clindamycin and cefalexin were administered for 48 hours as prophylactic antibiotics. Patients and Methods: In this clinical trial study, women with emergency cesarean section were divided into two groups. Intervention was oral administration of cefalexin 500mg every 6 hours and clindamycin 300 mg every 6 hours for 48 hours. All participants were referred to the gynecology center on day 7–10, at the time of removal of the sutures, and within 30 days after cesarean section, to assess the presence or absence of wound infection after surgery during 30 days. Results: In this clinical trial study, 462 pregnant women undergoing cesarean section were enrolled in the intervention and control groups. Of 231 patients in the intervention group, 15 women (6.5%) had cesarean section infection (13 cases with superficial, and 2 cases with deep infection). In the control group, 45 cases (19.5%) had cesarean section infection (31 cases with superficial, 10 cases with deep, and 4 cases with developed pelvic infection) (P = 0.001). Age, pre-cesarean length of stay, pre-term incision, type of incision, discharge longer than 18 hours after cesarean section, and maternal diabetes were significantly different regarding cesarean section infection in both groups. The frequency of cesarean section infection was less in the intervention group (P <0.001). Conclusion: Administration of prophylactic antibiotic can have a significant role in reducing cesarean section infection. Trial Registration: Registration of trial protocol has been approved in Thailand registry of clinical trials (identifier: TCTR20201204002, http://www.clinicaltrials.in.th/index.php?tp=regtrials & menu=trialsearch & s-menu=fulltext & task=search & task2=view1 & id=7120, ethical code; IR.UMSU.REC.1397.323).
format article
author Farzaneh Broumand
Naghmeh Zand Vakili
Zahra Yekta
Shabnam Vazifekhah
author_facet Farzaneh Broumand
Naghmeh Zand Vakili
Zahra Yekta
Shabnam Vazifekhah
author_sort Farzaneh Broumand
title Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
title_short Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
title_full Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
title_fullStr Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
title_full_unstemmed Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
title_sort comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial
publisher Society of Diabetic Nephropathy Prevention
publishDate 2022
url https://doaj.org/article/be18b11691914cc3809cac5d3b9944f6
work_keys_str_mv AT farzanehbroumand comparativestudyofsurgicalsiteinfectionwithorwithoutpostcesareanprophylacticoralantibioticsasingleblindedrandomizedclinicaltrial
AT naghmehzandvakili comparativestudyofsurgicalsiteinfectionwithorwithoutpostcesareanprophylacticoralantibioticsasingleblindedrandomizedclinicaltrial
AT zahrayekta comparativestudyofsurgicalsiteinfectionwithorwithoutpostcesareanprophylacticoralantibioticsasingleblindedrandomizedclinicaltrial
AT shabnamvazifekhah comparativestudyofsurgicalsiteinfectionwithorwithoutpostcesareanprophylacticoralantibioticsasingleblindedrandomizedclinicaltrial
_version_ 1718426571634638848